ACTU Market Cap History



Below is a table of the ACTU market cap history going back to 3/10/2025:

Date ACTU Market Cap
3/10/2025142.19M

Also see: ACTU Shares Outstanding History
and ACTU YTD Return
Mouse over chart for data details
3/10/2025
Actuate Therapeutics is a clinical stage biopharmaceutical company that engaged in the developing therapies for the treatment of cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). Co. is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3ß, thereby causing the death of the cancer cells and the regulation of anti-tumor immunity. Co. operates as a semi-virtual biopharmaceutical company with expertise in all aspects of preclinical and clinical development. We show 1 historical shares outstanding datapoints in our ACTU shares outstanding history coverage, used to compute ACTU market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACTU market cap history over the course of time is important for investors interested in comparing ACTU's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACTU versus a peer is one thing; comparing ACTU market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACTU can fluctuate over the course of history. With this page we aim to empower investors researching ACTU by allowing them to research the ACTU market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ACTU Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Actuate Therapeutics (ACTU) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACXP Market Cap History
ADGI Market Cap History
ADIL Market Cap History
ADMA Market Cap History
ADMP Market Cap History
ADMS Market Cap History
ADPT Market Cap History
ADRO Market Cap History
ADTX Market Cap History
ADUS Market Cap History
More Healthcare companies »

 

ACTU Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.